INSIGHTS

Introduction : The Unified Patent Court (UPC) has rapidly become one of the most consequential forums for pharmaceutical patent disputes in Europe. For innovator companies, generic manufacturers, and biosimilar developers, the UPC offers a single procedural route capable of producing enforceable remedies across multiple European Union member states. Its early pharmaceutical case law has already shaped key issues such as preliminary injunctions, evidence preservation, the scop